Rush Medical Center Home Page Information for healthcare Professionals Rush University
FIND A DOCTOR
PATIENT & VISTOR SERVICES
HEALTH INFORMATION
CLINICAL SERVICES
EVENTS & CLASSES
RUSH NEWS ROOM
CLINICAL TRIALS
RESEARCH AT RUSH
NURSING AT RUSH
WORK AT RUSH
GIVING TO RUSH

Bookmark This Page
Clinical Trails at Rush Cardiovascular Disease Trials
Contact Name Clinical Trials at Rush
Contact E-mail clinical_trials@rush.edu

Click on the links below to learn about clinical research trials in cardiovascular disease. If you would like to make an appointment with a physician at Rush, call (888) 352-RUSH, our toll-free referral line.

Included in this section:

Atrial Septal Defects Quality of Life Study: The purpose of this study is to explore the quality of life in adults newly diagnosed with an atrial septal defect. An ASD is a hole between the upper chambers of the heart.

Bridge Study: Bridging Anticoagulation : The Bridge study will determine whether a bridging blood thinner called dalteparin is helpful or harmful for people with atrial fibrillation who stop taking warfarin in preparation for surgery or another procedure.

CABANA: Comparing Catheter Ablation & Drug Therapy for Atrial Fibrillation: The CABANA trial will explore the appropriate roles for medical and ablative intervention for atrial fibrillation (AF).

EVEREST II Clinical Trial: The purpose of this study is to continue evaluation and monitoring of the safety and effectiveness of an investigational device that repairs the mitral valve.

GORE Reduce Study: Goal of trial is to demonstrate that patent foramen ovale closure with the GORE HELEX Septal Occluder plus antiplatelet medical management is safe and effective and reduces risk of recurrent stroke or imaging-confirmed transient ischemic attack when compared to antiplatelet medical management alone.

IxCELL-DCM: Stem Cell Study: The purpose of the ixCELL-DCM Study is to evaluate the safety and efficacy of using stem cells from the patient's own bone marrow to treat chronic congestive heart failure due to ischemic dilated cardiomyopathy.

The PARTNER II Trial: The purpose of this trial is to determine the safety and effectiveness of an aortic valve device in patients with critical narrowing of the aortic valve that are deemed high risk and are not surgical candidates.



Promotional Information

Clinical Trials Home
Cardiovascular Disease Trials
Atrial Septal Defects Quality of Life Study
Bridging Anticoagulation
CABANA Atrial Fibrillation Treatment Comparing Trial
EVEREST II Clinical Trial
GORE Reduce Study
The PARTNER II Trial
ixCELL-DCM: Stem Cell Study

   
Find a Doctor | Patient & Visitor Services | Health Information
Clinical Services | Events & Classes | Rush News Room | Clinical Trials
Research At Rush
Disclaimer | Privacy Statement | Site Map

© Rush University Medical Center, Chicago, Illinois